Barclays Sticks to Its Hold Rating for Icon plc (ICLR)


Barclays analyst Jack Meehan maintained a Hold rating on Icon plc (ICLR) today and set a price target of $140. The company’s shares opened today at $143.

According to TipRanks.com, Meehan is a 4-star analyst with an average return of 6.6% and a 64.9% success rate. Meehan covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, IQVIA Holdings Inc, and Syneos Health Inc.

Currently, the analyst consensus on Icon plc is a Moderate Buy with an average price target of $145.

See today’s analyst top recommended stocks >>

Icon plc’s market cap is currently $7.94B and has a P/E ratio of 25.85. The company has a Price to Book ratio of 5.95.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ICON plc is a contract research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It operates through the following geographical segments: Ireland, Rest of Europe, United States, and Other.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts